Marshfield Clinic Research Foundation

Alternate name: MCRF

Country: US

ROR: 03sqpx865

Crossref ID: 100011624

DOI: 10.13039/100011624

OpenAlex ID: F4320312903

JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression

2019 · Katie L. Owen, Natasha K. Brockwell, et al. · Cancers · 738

PDF

Taurine deficiency as a driver of aging

2023 · Parminder Singh, Kishore Gollapalli, et al. · Science · 482

PDF

Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy

2021 · Jian Kang, Natalie Brajanovski, et al. · Signal Transduction and Targeted Therapy · 443

PDF

Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation

2017 · David S. Liu, Cuong P. Duong, et al. · Nature Communications · 335

PDF

MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death

2017 · Isabel Jaco, Alessandro Annibaldi, et al. · Molecular Cell · 318

PDF

Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk

2019 · Charles E. Matthews, Steven C. Moore, et al. · Journal of Clinical Oncology · 313

PDF

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

2018 · Delphine Merino, Gemma L. Kelly, et al. · Cancer Cell · 300

PDF

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

2024 · Jack D. Chan, Christina M. Scheffler, et al. · Nature · 274

PDF

2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

2016 · Richard K. Zimmerman, Mary Patricia Nowalk, et al. · Clinical Infectious Diseases · 270

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy

2021 · Lauren Giuffrida, Kevin Sek, et al. · Nature Communications · 247

PDF

BECLIN1: Protein Structure, Function and Regulation

2021 · Sharon Tran, W. Douglas Fairlie, et al. · Cells · 244

PDF

Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies

2019 · Fiona H Tan, Tracy L Putoczki, et al. · OncoTargets and Therapy · 211

PDF

Big Data Analytics for Genomic Medicine

2017 · Karen He, Dongliang Ge, et al. · International Journal of Molecular Sciences · 188

PDF

Arginase-2 is Essential for IL-10 Metabolic Reprogramming of Inflammatory Macrophages at the Mitochondria

2020 · Jennifer K. Dowling, Remsha Afzal, et al. · Nature Communications · 181

PDF

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

2020 · John T. Poirier, Julie George, et al. · Journal of Thoracic Oncology · 179

PDF

Should mutant TP53 be targeted for cancer therapy?

2022 · Zilu Wang, Andreas Strasser, et al. · Cell Death and Differentiation · 167

PDF

STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression

2020 · Jesse J. Balic, Hassan Albargy, et al. · Nature Communications · 163

PDF

Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues

2019 · Arthe Raajendiran, Geraldine Ooi, et al. · Cell Reports · 160

PDF

Characterization of Three Corticotropin-Releasing Factor Receptors in Catfish: A Novel Third Receptor Is Predominantly Expressed in Pituitary and Urophysis

2001 · Maya Arai, Iman Q. Assil, et al. · Endocrinology · 154

Future Therapeutic Directions for Smac-Mimetics

2020 · Emma Morrish, Gabriela Brumatti, et al. · Cells · 153

PDF

Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups

2020 · Ozan Dikilitas, Daniel J. Schaid, et al. · The American Journal of Human Genetics · 148

PDF

Global redox proteome and phosphoproteome analysis reveals redox switch in Akt

2019 · Zhiduan Su, James G. Burchfield, et al. · Nature Communications · 148

PDF

Cross-talk between protein synthesis, energy metabolism and autophagy in cancer

2017 · Lisa M Lindqvist, Kristofferson Tandoc, et al. · Current Opinion in Genetics & Development · 143

PDF

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

2021 · Rachel Thijssen, Sarah T. Diepstraten, et al. · Blood · 142

PDF

Identification of Pik3ca Mutation as a Genetic Driver of Prostate Cancer That Cooperates with Pten Loss to Accelerate Progression and Castration-Resistant Growth

2018 · Helen B. Pearson, Jason Li, et al. · Cancer Discovery · 138

PDF

Works count: 419

Citation count: 14,970

H-index: 59

I10-index: 249

2-year mean citedness: 11.84

Awards count: 22